Riskpilot← Back to searchSign inGet full accessSpirel AB
ABActiveOrg 5568766017Fersens Väg 3Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20111-4 employees
Revenue 2025
SEK 5,6M
-22% vs 2024
EBITDA margin
-9.8%
-128% vs 2024
Equity ratio
5.7%
Financial strength
Net profit 2025
SEK -643K
-87% vs 2024
| Revenue | SEK 5,6M | -22% |
| EBITDA | SEK -553K | -128% |
| Net profit | SEK -643K | -87% |
| Total assets | SEK 1,5M | -25% |
| Equity | SEK 83K | +10% |
| Employees | — | — |
Legal name
Spirel AB
Org number
5568766017
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15 december 2011
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom sjukvård samt agenturverksamhet inom sjukvårdsartiklar samt därmed förenlig verksamhet.
Address
Fersens Väg 3
Phone
+4670241556
Email
peter.cnattingius@spirel.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 043 | 5 249 | 7 127 | 7 240 | 5 626 |
| Staff expenses | — | — | — | — | −935 |
| EBITDA | 97 | 73 | 202 | −242 | −553 |
| Depreciation & amort. | −38 | −38 | −38 | −38 | −38 |
| EBIT | 59 | 35 | 164 | −280 | −591 |
| Net financials | −17 | −27 | −53 | −63 | −53 |
| Profit before tax | 42 | 8 | 111 | −343 | −643 |
| Tax | −33 | −33 | −54 | −1 | — |
| Net profit | 9 | −25 | 57 | −344 | −643 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 936 | 2 352 | 2 484 | 1 928 | 1 456 |
| Equity | 89 | 64 | 120 | 76 | 83 |
| Long-term debt | 795 | 897 | 794 | 986 | 224 |
| Short-term debt | 1 052 | 1 391 | 1 569 | 866 | 1 149 |
| Total debt | 1 847 | 2 288 | 2 363 | 1 852 | 1 372 |
EBITDA margin
-9.8%
This company
15.8%
Market median
-162% vs market
20212025
Equity ratio
5.7%
This company
38.2%
Market median
-85% vs market
20212025
Return on equity
-772.5%
This company
18.4%
Market median
-4298% vs market
20212025
Net profit margin
-11.4%
This company
8.1%
Market median
-241% vs market
20212025
Asset turnover
3.87×
This company
1.12×
Market median
+246% vs market
20212025
Debt / equity
16.48×
This company
0.62×
Market median
-2558% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CM Chief Auditor | Chief Auditor | 2025 |
BP Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
OC | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
P. Cnattingius AB
Spirel AB Board members of Spirel AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Magnus Thunström | Chief Auditor | 0 companies |
| Ove Christofer Hultén | Audit | 0 companies |
| Bo Peter Cnattingius | Chief Executive Officer | 0 companies |
| Una Louise Albertsson Cnattingius | Deputy Board Member | 0 companies |